148 related articles for article (PubMed ID: 15588688)
1. Cytokine and anti-cytokine therapy for the treatment of asthma and allergic disease.
Holgate ST
Cytokine; 2004 Nov 21-Dec 7; 28(4-5):152-7. PubMed ID: 15588688
[TBL] [Abstract][Full Text] [Related]
2. Agents against cytokine synthesis or receptors.
Yamagata T; Ichinose M
Eur J Pharmacol; 2006 Mar; 533(1-3):289-301. PubMed ID: 16457805
[TBL] [Abstract][Full Text] [Related]
3. Individual cytokines contributing to asthma pathophysiology: valid targets for asthma therapy?
Chung KF
Curr Opin Investig Drugs; 2003 Nov; 4(11):1320-6. PubMed ID: 14758771
[TBL] [Abstract][Full Text] [Related]
4. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
5. Anti-immunoglobulin E treatment with omalizumab in allergic diseases: an update on anti-inflammatory activity and clinical efficacy.
Holgate ST; Djukanović R; Casale T; Bousquet J
Clin Exp Allergy; 2005 Apr; 35(4):408-16. PubMed ID: 15836747
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of omalizumab in patients with inadequately controlled severe persistent allergic asthma: an open-label study.
Niven R; Chung KF; Panahloo Z; Blogg M; Ayre G
Respir Med; 2008 Oct; 102(10):1371-8. PubMed ID: 18657960
[TBL] [Abstract][Full Text] [Related]
7. Effect of omalizumab treatment on peripheral eosinophil and T-lymphocyte function in patients with allergic asthma.
Noga O; Hanf G; Brachmann I; Klucken AC; Kleine-Tebbe J; Rosseau S; Kunkel G; Suttorp N; Seybold J
J Allergy Clin Immunol; 2006 Jun; 117(6):1493-9. PubMed ID: 16751018
[TBL] [Abstract][Full Text] [Related]
8. Role of anti-IgE monoclonal antibody (omalizumab) in the treatment of bronchial asthma and allergic respiratory diseases.
D'Amato G
Eur J Pharmacol; 2006 Mar; 533(1-3):302-7. PubMed ID: 16464445
[TBL] [Abstract][Full Text] [Related]
9. Anti-TNF-alpha and Th1 cytokine-directed therapies for the treatment of asthma.
Cazzola M; Polosa R
Curr Opin Allergy Clin Immunol; 2006 Feb; 6(1):43-50. PubMed ID: 16505611
[TBL] [Abstract][Full Text] [Related]
10. Anti-IgE antibodies for the treatment of IgE-mediated allergic diseases.
Chang TW; Wu PC; Hsu CL; Hung AF
Adv Immunol; 2007; 93():63-119. PubMed ID: 17383539
[TBL] [Abstract][Full Text] [Related]
11. Immunoglobulin E: role in asthma and allergic disease: lessons from the clinic.
Owen CE
Pharmacol Ther; 2007 Jan; 113(1):121-33. PubMed ID: 17000005
[TBL] [Abstract][Full Text] [Related]
12. Novel 2-(substituted phenyl)benzimidazole derivatives with potent activity against IgE, cytokines, and CD23 for the treatment of allergy and asthma.
Richards ML; Lio SC; Sinha A; Tieu KK; Sircar JC
J Med Chem; 2004 Dec; 47(26):6451-4. PubMed ID: 15588078
[TBL] [Abstract][Full Text] [Related]
13. Omalizumab in the treatment of severe asthma: efficacy and current problems.
Pelaia G; Renda T; Romeo P; Busceti MT; Maselli R
Ther Adv Respir Dis; 2008 Dec; 2(6):409-21. PubMed ID: 19124386
[TBL] [Abstract][Full Text] [Related]
14. Immunomodulators for allergic respiratory disorders.
Casale TB; Stokes JR
J Allergy Clin Immunol; 2008 Feb; 121(2):288-96; quiz 297-8. PubMed ID: 18269921
[TBL] [Abstract][Full Text] [Related]
15. Asthma treatment: 'magic bullets which seek their own targets'.
Tarantini F; Baiardini I; Passalacqua G; Braido F; Canonica GW
Allergy; 2007 Jun; 62(6):605-10. PubMed ID: 17508963
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological approaches.
Avila PC; Kishiyama JL; Adelman DC
Clin Allergy Immunol; 2002; 16():469-94. PubMed ID: 11577555
[TBL] [Abstract][Full Text] [Related]
17. Anti-immunoglobulin E therapy with omalizumab for asthma.
Hendeles L; Sorkness CA
Ann Pharmacother; 2007 Sep; 41(9):1397-410. PubMed ID: 17698897
[TBL] [Abstract][Full Text] [Related]
18. Anti-IgE therapy with omalizumab in asthma and allergic rhinitis.
Dodig S; Richter D; Cepelak I; Benko B
Acta Pharm; 2005 Jun; 55(2):123-38. PubMed ID: 16179127
[TBL] [Abstract][Full Text] [Related]
19. Preclinical safety and pharmacology of an anti-human interleukin-13 monoclonal antibody in normal macaques and in macaques with allergic asthma.
Martin PL; Fisher D; Glass W; O'Neil K; Das A; Martin EC; Li L
Int J Toxicol; 2008; 27(5):351-8. PubMed ID: 19037805
[TBL] [Abstract][Full Text] [Related]
20. Management of asthma with anti-immunoglobulin E: a review of clinical trials of omalizumab.
Nowak D
Respir Med; 2006 Nov; 100(11):1907-17. PubMed ID: 16949266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
